 In November 2009, Omnicare paid $98 million to the federal government to settle five qui tam lawsuits brought under the "False Claims Act" and government charges that the company had paid or solicited a variety of kickbacks.The company admitted no wrongdoing.The charges included allegations that Omnicare solicited and received kickbacks from a pharmaceutical manufacturer Johnson & Johnson, in exchange for agreeing to recommend that physicians prescribe Risperdal, a Johnson & Johnson antipsychotic drug, to nursing home patients.